Publication: Outcomes of SARS-CoV-2 infected pregancies after medically assisted reproduction
dc.contributor.coauthor | Gianaroli, Luca | |
dc.contributor.coauthor | Lundin, Kersti | |
dc.contributor.coauthor | Mcheik, Saria | |
dc.contributor.coauthor | Mocanu, Edgar | |
dc.contributor.coauthor | Rautakallio-Hokkanen, Satu | |
dc.contributor.coauthor | Tapanainen, Juha S. | |
dc.contributor.coauthor | Vermeulen, Nathalie | |
dc.contributor.coauthor | Veiga, Anna | |
dc.contributor.coauthor | Eshre COVID-19 Working Group | |
dc.contributor.kuauthor | Ata, Mustafa Barış | |
dc.contributor.kuprofile | Faculty Member | |
dc.contributor.schoolcollegeinstitute | School of Medicine | |
dc.contributor.yokid | 182910 | |
dc.date.accessioned | 2024-11-09T13:47:21Z | |
dc.date.issued | 2022 | |
dc.description.abstract | Study question: what is the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on the outcome of a pregnancy after medically assisted reproduction (MAR)?. Summary answer: our results suggest that MAR pregnancies are not differentially affected by SARS-CoV-2 infection compared to spontaneous pregnancies. What is known already: information on the effects of coronavirus disease 2019 (COVID-19) on pregnancy after MAR is scarce when women get infected during MAR or early pregnancy, even though such information is vital for informing women seeking pregnancy. Study design, size, duration: data from SARS-CoV-2 affected MAR pregnancies were collected between May 2020 and June 2021 through a voluntary data collection, organised by the European Society of Human Reproduction and Embryology (ESHRE). Participants/materials, setting, methods: all ESHRE members were invited to participate to an online data collection for SARS-CoV-2-infected MAR pregnancies. Main results and the role of chance: the dataset includes 80 cases from 32 countries, including 67 live births, 10 miscarriages, 2 stillbirths and 1 maternal death. An additional 25pregnancies were ongoing at the time of writing. Limitations, reasons for caution: an international data registry based on voluntary contribution can be subject to selective reporting with possible risks of over- or under-estimation. Wider implications of the findings: the current data can be used to guide clinical decisions in the care of women pregnant after MAR, in the context of the COVID-19 pandemic. | |
dc.description.fulltext | YES | |
dc.description.indexedby | WoS | |
dc.description.indexedby | Scopus | |
dc.description.indexedby | PubMed | |
dc.description.issue | 11 | |
dc.description.openaccess | YES | |
dc.description.publisherscope | International | |
dc.description.sponsoredbyTubitakEu | N/A | |
dc.description.sponsorship | N/A | |
dc.description.version | Publisher version | |
dc.description.volume | 36 | |
dc.format | ||
dc.identifier.doi | 10.1093/humrep/deab218 | |
dc.identifier.eissn | 1460-2350 | |
dc.identifier.embargo | NO | |
dc.identifier.filenameinventoryno | IR03201 | |
dc.identifier.issn | 0268-1161 | |
dc.identifier.link | https://doi.org/10.1093/humrep/deab218 | |
dc.identifier.quartile | Q1 | |
dc.identifier.scopus | 2-s2.0-85119303885 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/3762 | |
dc.identifier.wos | 743765900008 | |
dc.keywords | SARS-CoV-2 | |
dc.keywords | COVID-19 | |
dc.keywords | Medically assisted reproduction | |
dc.keywords | ESHRE | |
dc.keywords | Pregnancy | |
dc.keywords | IVF | |
dc.language | English | |
dc.publisher | Oxford University Press (OUP) | |
dc.relation.grantno | NA | |
dc.relation.uri | http://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/9963 | |
dc.source | Human Reproduction | |
dc.subject | Obstetrics and gynecology | |
dc.subject | Reproductive biology | |
dc.title | Outcomes of SARS-CoV-2 infected pregancies after medically assisted reproduction | |
dc.type | Journal Article | |
dspace.entity.type | Publication | |
local.contributor.authorid | 0000-0003-1106-3747 | |
local.contributor.kuauthor | Ata, Mustafa Barış |
Files
Original bundle
1 - 1 of 1